Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026)
Bristol Myers Squibb's Other Assets was $6.1 billion in Q3 2026, down 3.7% from $6.33 billion a year earlier and down 4.4% from the prior quarter.
Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Other Assets at Bristol Myers Squibb came in at $6.47 billion, up 6.0% from FY2024.
- Other Assets has now increased for three consecutive years, though with a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- In earlier years, Other Assets was $6.11 billion in FY2024 (+13.7%), $5.37 billion in FY2023 (+8.7%), $4.94 billion in FY2022 (-10.7%) and $5.54 billion in FY2021 (-21.1%).
- Quarterly Other Assets has moved between $53 million (Q1 2023) and $6.47 billion (Q4 2025) over five years.
- Compared with a year earlier, Other Assets was higher in five of the last eight quarters, with growth averaging 3.4%.
- The best year-over-year quarter for Other Assets over five years was Q4 2024 (growth of 13.7%); the worst was Q1 2022 (a decline of 97.1%).
- Per Business Quant data, BMY's Other Assets in the three quarters before Q3 2026 was $6.38 billion (Q2 2026), $6.08 billion (Q1 2026) and $6.47 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 6.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.10 Bn |
| Jun 30, 2026 | 6.38 Bn |
| Mar 31, 2026 | 6.08 Bn |
| Dec 31, 2025 | 6.47 Bn |
| Sep 30, 2025 | 6.33 Bn |
| Jun 30, 2025 | 5.94 Bn |
| Mar 31, 2025 | 5.87 Bn |
| Dec 31, 2024 | 6.11 Bn |
| Sep 30, 2024 | 6.04 Bn |
| Jun 30, 2024 | 6.07 Bn |
| Mar 31, 2024 | 6.02 Bn |
| Dec 31, 2023 | 5.37 Bn |
| Sep 30, 2023 | 54.00 Mn |
| Jun 30, 2023 | 53.00 Mn |
| Mar 31, 2023 | 53.00 Mn |
| Dec 31, 2022 | 4.94 Bn |
| Sep 30, 2022 | 223.00 Mn |
| Jun 30, 2022 | 210.00 Mn |
| Mar 31, 2022 | 210.00 Mn |
| Dec 31, 2021 | 5.54 Bn |
Bristol Myers Squibb Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();